Pretreatment Histopathology-Based Tumor Microenvironment Modeling Predicts Treatment-Specific Objective Responses in Non-small Cell Lung Cancer

Accurate prediction of treatment response remains challenging in cancer. To facilitate response prediction in non-small cell lung cancer (NSCLC), we developed PRISM, an interpretable multiscale graph-learning framework for estimating treatment-specific objective response from pretreatment H&E whole-slide images. PRISM integrated multiresolution tissue representations with a cell-level tumor microenvironment (TME) hypergraph, thereby treating higher-order microenvironmental organization as a learnable component of treatment-response prediction. Samples from 7,082 patients from four Chinese centers were screened. PRISM was evaluated across treatment specific cohorts receiving targeted therapy (T), EGFR-targeted therapy (T_EGFR), immune checkpoint inhibitor–based therapy (ICI), chemoimmunotherapy (CI), and chemotherapy (C) using patient-level internal cross-validation, independent multicenter external validation, and prospective silent validation. PRISM predicted early objective responses across prespecified systemic therapies in NSCLC. In comparison to 18 established multiple-instance learning and computational pathology baseline models, PRISM remained competitive, with numerical advantages in selected tasks. Multiscale attribution and exploratory H&E-derived TME analyses provided spatial context for model predictions. Overall, PRISM offers a morphology-based framework for estimating early response to prespecified systemic therapies and warrants further prospective multicenter evaluation.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-11-19
DOI
https://doi.org/10.1158/0008-5472.can-26-1365
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pretreatment Histopathology-Based Tumor Microenvironment Modeling Predicts Treatment-Specific Objective Responses in Non-small Cell Lung Cancer

聂德林, Qiya Song, Liangrui Pan, Desheng Xiao et al.
Cancer Research
AI in cancer detection
article

Pretreatment Histopathology-Based Tumor Microenvironment Modeling Predicts Treatment-Specific Objective Responses in Non-small Cell Lung Cancer

聂德林, Qiya Song, Liangrui Pan, Desheng Xiao, Yang Liu, Xiang Wang, Zhihong Chen, Ling Xiao, Xiong Peng, Qiankun Li, Yaning Yang, Chenchen Nie, Qide Liang, Jiayu Qian, Bin Xie, Fanghua Hu
article en

Abstract

Accurate prediction of treatment response remains challenging in cancer. To facilitate response prediction in non-small cell lung cancer (NSCLC), we developed PRISM, an interpretable multiscale graph-learning framework for estimating treatment-specific objective response from pretreatment H&E whole-slide images. PRISM integrated multiresolution tissue representations with a cell-level tumor microenvironment (TME) hypergraph, thereby treating higher-order microenvironmental organization as a learnable component of treatment-response prediction. Samples from 7,082 patients from four Chinese centers were screened. PRISM was evaluated across treatment specific cohorts receiving targeted therapy (T), EGFR-targeted therapy (T_EGFR), immune checkpoint inhibitor–based therapy (ICI), chemoimmunotherapy (CI), and chemotherapy (C) using patient-level internal cross-validation, independent multicenter external validation, and prospective silent validation. PRISM predicted early objective responses across prespecified systemic therapies in NSCLC. In comparison to 18 established multiple-instance learning and computational pathology baseline models, PRISM remained competitive, with numerical advantages in selected tasks. Multiscale attribution and exploratory H&E-derived TME analyses provided spatial context for model predictions. Overall, PRISM offers a morphology-based framework for estimating early response to prespecified systemic therapies and warrants further prospective multicenter evaluation.

Cancer Research
Central South University (CN), Nanyang Technological University (SG), Hunan Normal University (CN), Zhengzhou University (CN), Hunan Cancer Hospital (CN), Second Xiangya Hospital of Central South University (CN), Xiangya Hospital Central South University (CN), Xiangtan University (CN)
AI in cancer detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon